Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) EBITDA Margin (2019 - 2025)

Historic EBITDA Margin for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to 858.86%.

  • Volitionrx's EBITDA Margin rose 4077900.0% to 858.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 1604.61%, marking a year-over-year increase of 7518600.0%. This contributed to the annual value of 2198.3% for FY2024, which is 24012300.0% up from last year.
  • As of Q3 2025, Volitionrx's EBITDA Margin stood at 858.86%, which was up 4077900.0% from 1694.19% recorded in Q2 2025.
  • Volitionrx's EBITDA Margin's 5-year high stood at 858.86% during Q3 2025, with a 5-year trough of 61692.56% in Q4 2021.
  • In the last 5 years, Volitionrx's EBITDA Margin had a median value of 5097.66% in 2023 and averaged 12078.7%.
  • In the last 5 years, Volitionrx's EBITDA Margin skyrocketed by 2000000000bps in 2021 and then skyrocketed by 837800bps in 2025.
  • Over the past 5 years, Volitionrx's EBITDA Margin (Quarter) stood at 61692.56% in 2021, then surged by 90bps to 6201.93% in 2022, then skyrocketed by 42bps to 3605.06% in 2023, then rose by 19bps to 2928.08% in 2024, then soared by 71bps to 858.86% in 2025.
  • Its last three reported values are 858.86% in Q3 2025, 1694.19% for Q2 2025, and 2325.85% during Q1 2025.